CELLULAR BIOMEDICINE GROUP I - COM NEW (CBMG)

CUSIP: 15117P102

Q4 2014 13F Holders as of 31 Dec 2014

Type / Class
Equity / COM NEW
Total 13F shares
32,386
Share change
+4,968
Total reported value
$416,000
Price per share
$12.77
Number of holders
5
Value change
+$31,685
Number of buys
1
Number of sells
4

Quarterly Holders Quick Answers

What is CUSIP 15117P102?
CUSIP 15117P102 identifies CBMG - CELLULAR BIOMEDICINE GROUP I - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CELLULAR BIOMEDICINE GROUP I - COM NEW (CBMG) as of Q4 2014

As of 31 Dec 2014, CELLULAR BIOMEDICINE GROUP I - COM NEW (CBMG) was held by 5 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 32,386 shares. The largest 5 holders included GEODE CAPITAL MANAGEMENT, LLC, GOLDMAN SACHS GROUP INC, UBS Group AG, BlackRock Institutional Trust Company, N.A., and MetLife Securities, Inc. This page lists 5 institutional shareholders reporting positions in this security for the Q4 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.